Acrylamide and Potential Risk of Diabetes Mellitus: Effects on Human Population, Glucose Metabolism and Beta-Cell Toxicity
Overview
Chemistry
Molecular Biology
Affiliations
Diabetes mellitus is a frequent endocrine disorder characterized by hyperglycemia. Acrylamide (AA) is food contaminant formed during the high-temperature processing of food rich in carbohydrates and low in proteins. Recent human epidemiological studies have shown a potential association between AA exposure and the prevalence of diabetes in the general population. In male rats, AA treatment promoted pancreatic islet remodeling, which was determined by alpha-cell expansion and beta-cell reduction, while in female rats AA caused hyperglycemia and histopathological changes in pancreatic islets. In vitro and in vivo rodent model systems have revealed that AA induces oxidative stress in beta cells and that AA impairs glucose metabolism and the insulin signaling pathway. Animal studies have shown that diabetic rodents are more sensitive to acrylamide and that AA aggravates the diabetic state. In this review, we provide an overview of human epidemiological studies that examined the relation between AA exposure and glucose disorders. In addition, the effects of AA treatment on pancreatic islet structure, beta-cell function and glucose metabolism in animal models are comprehensively analyzed with an emphasis on sex-related responses. Furthermore, oxidative stress as a putative mechanism of AA-induced toxicity in beta cells is explored. Finally, we discuss the effects of AA on diabetics in a rodent model system.
Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide.
Wang X, Zhang R, Pan Y, Li Z, Li H, Lei Y Cell Biosci. 2024; 14(1):106.
PMID: 39180059 PMC: 11344312. DOI: 10.1186/s13578-024-01285-7.
Food contaminants and potential risk of diabetes development: A narrative review.
Milanovic M, Milosevic N, Milic N, Medic Stojanoska M, Petri E, Markovic Filipovic J World J Diabetes. 2023; 14(6):705-723.
PMID: 37383596 PMC: 10294057. DOI: 10.4239/wjd.v14.i6.705.
Hosseini-Esfahani F, Beheshti N, Nematollahi A, Koochakpoor G, Verij-Kazemi S, Mirmiran P Sci Rep. 2023; 13(1):8235.
PMID: 37217800 PMC: 10203125. DOI: 10.1038/s41598-023-35493-x.
Mannino G, Mancuso E, Sbrignadello S, Morettini M, Andreozzi F, Tura A Int J Environ Res Public Health. 2022; 19(24).
PMID: 36554367 PMC: 9778390. DOI: 10.3390/ijerph192416489.
Banc R, Popa D, Cozma-Petrut A, Filip L, Kiss B, Farcas A Antioxidants (Basel). 2022; 11(7).
PMID: 35883838 PMC: 9312107. DOI: 10.3390/antiox11071347.